Breast Cancer Symptoms, Diagnosis, Prognosis and Treatment News

May 25, 2018May 25, 2018
Dacogen Shows Promise in Triple-negative Breast Cancer Animal Models, Study Shows
News
Dacogen (decitabine), a medicine used for treating a group of blood cell disorders, may be a potential new treatment ... Read more
May 23, 2018
Imagion’s Breast Cancer Detection Method Using Magnetic Nanoparticles Moving into Clinical Trials
News
Imagion Biosystems‘ experimental breast cancer detection method — involving magnetic nanoparticles that stick to breast cancer cells — will ... Read more
May 22, 2018May 22, 2018
Let Them Eat Pancakes
A Lump in the Road - A Column by Nancy Brier, Columns
I raised my hand and suddenly, life changed. “What the hell were you thinking?” Gary said when I got ... Read more
May 21, 2018
Herceptin Treatment Time Could be Halved for Breast Cancer, Phase 3 Trial Finds
News
A shorter Herceptin (trastuzumab) treatment — six months instead of the standard 12 months — is equally effective and carries fewer ... Read more
May 18, 2018
Program Offering Financial Incentives Encourages Breast Cancer Patients to Exercise More, Study Finds
News
Physical exercise may help breast cancer survivors overcome many of the side effects associated with cancer therapy, but studies ... Read more
May 16, 2018May 16, 2018
Breast Cancer ‘Screening Pill’ Could Be on the Horizon, Mice Study Shows
News
Researchers have developed a pill that marks tumors and lights them up when exposed to infrared light, which could ... Read more
May 15, 2018May 14, 2018
A Holistic Approach to My Husband’s Watermelon Belly
A Lump in the Road - A Column by Nancy Brier, Columns
I pasted a photo of my husband’s belly into an email and hit send. “That felt odd,” I ... Read more
May 14, 2018May 14, 2018
Study Discovers Mutations That Cause Resistance to Lynparza, Similar Therapies
News
Researchers have identified mutations in the poly (ADP-ribose) polymerase (PARP) gene that cause resistance to the cancer therapy Lynparza (olaparib) and ... Read more
May 11, 2018
OncoSec, Merck Partner to Test Immunotherapy Combo in Phase 2 Trial for Triple-negative Breast Cancer
News
OncoSec Medical and Merck have joined efforts to conduct a Phase 2 trial evaluating the safety and effectiveness of ... Read more
May 9, 2018May 9, 2018
Poor Prognosis for Breast Cancers Diagnosed After Negative Screening Mammography
News
While occurring at low rates, breast cancer cases diagnosed after a negative mammography screening are linked to poorer prognosis ... Read more
May 8, 2018May 9, 2018
My Body, Like My House, Is Under Construction
A Lump in the Road - A Column by Nancy Brier, Columns
“I had another chemo nap,” I told my husband recently. “I know,” he said. “We ate dinner without ... Read more
May 7, 2018May 7, 2018
Possible Reasons Why Tyverb/Tykerb Fails as Breast Cancer Monotherapy Explored in Study
News
Lapatinib, an approved medicine for advanced breast cancer available under the brand names Tyverb in Europe and Tykerb ... Read more

May 25, 2018May 25, 2018

Dacogen Shows Promise in Triple-negative Breast Cancer Animal Models, Study Shows

News

Dacogen (decitabine), a medicine used for treating a group of blood cell disorders, may be a potential new treatment for women with triple-negative breast cancer, including those who failed ... Read more

May 23, 2018

Imagion’s Breast Cancer Detection Method Using Magnetic Nanoparticles Moving into Clinical Trials

News

Imagion Biosystems‘ experimental breast cancer detection method — involving magnetic nanoparticles that stick to breast cancer cells — will be tested in a clinical trial later this year, according ... Read more

May 22, 2018May 22, 2018

Let Them Eat Pancakes

A Lump in the Road - A Column by Nancy Brier, Columns

I raised my hand and suddenly, life changed. “What the hell were you thinking?” Gary said when I got home. At a meeting, during that awkward silent moment when ... Read more

May 21, 2018

Herceptin Treatment Time Could be Halved for Breast Cancer, Phase 3 Trial Finds

News

A shorter Herceptin (trastuzumab) treatment — six months instead of the standard 12 months — is equally effective and carries fewer heart-related adverse effects, a Phase 3 clinical trial found. The ... Read more

May 18, 2018

Program Offering Financial Incentives Encourages Breast Cancer Patients to Exercise More, Study Finds

News

Physical exercise may help breast cancer survivors overcome many of the side effects associated with cancer therapy, but studies show that up to 70% of patients don’t exercise enough. ... Read more

May 16, 2018May 16, 2018

Breast Cancer ‘Screening Pill’ Could Be on the Horizon, Mice Study Shows

News

Researchers have developed a pill that marks tumors and lights them up when exposed to infrared light, which could potentially replace mammography in the future, a study in mice ... Read more

May 15, 2018May 14, 2018

A Holistic Approach to My Husband’s Watermelon Belly

A Lump in the Road - A Column by Nancy Brier, Columns

I pasted a photo of my husband’s belly into an email and hit send. “That felt odd,” I said out loud to myself. Gary’s belly was the shape ... Read more

May 14, 2018May 14, 2018

Study Discovers Mutations That Cause Resistance to Lynparza, Similar Therapies

News

Researchers have identified mutations in the poly (ADP-ribose) polymerase (PARP) gene that cause resistance to the cancer therapy Lynparza (olaparib) and other PARP inhibitors. These mutations could help physicians predict which ... Read more

May 11, 2018

OncoSec, Merck Partner to Test Immunotherapy Combo in Phase 2 Trial for Triple-negative Breast Cancer

News

OncoSec Medical and Merck have joined efforts to conduct a Phase 2 trial evaluating the safety and effectiveness of ImmunoPulse IL-12 in combination with Keytruda (pembrolizumab) for the treatment ... Read more

May 9, 2018May 9, 2018

Poor Prognosis for Breast Cancers Diagnosed After Negative Screening Mammography

News

While occurring at low rates, breast cancer cases diagnosed after a negative mammography screening are linked to poorer prognosis compared to those diagnosed after a positive mammogram, an observational ... Read more

May 8, 2018May 9, 2018

My Body, Like My House, Is Under Construction

A Lump in the Road - A Column by Nancy Brier, Columns

“I had another chemo nap,” I told my husband recently. “I know,” he said. “We ate dinner without you.” That’s when I realized I had slept for four ... Read more

May 7, 2018May 7, 2018

Possible Reasons Why Tyverb/Tykerb Fails as Breast Cancer Monotherapy Explored in Study

News

Lapatinib, an approved medicine for advanced breast cancer available under the brand names Tyverb in Europe and Tykerb in the U.S., can sometimes cause breast cancer cells to grow ... Read more

Dacogen Shows Promise in Triple-negative Breast Cancer Animal Models, Study Shows

Imagion’s Breast Cancer Detection Method Using Magnetic Nanoparticles Moving into Clinical Trials

Let Them Eat Pancakes

Herceptin Treatment Time Could be Halved for Breast Cancer, Phase 3 Trial Finds

Program Offering Financial Incentives Encourages Breast Cancer Patients to Exercise More, Study Finds

Breast Cancer ‘Screening Pill’ Could Be on the Horizon, Mice Study Shows

A Holistic Approach to My Husband’s Watermelon Belly

Study Discovers Mutations That Cause Resistance to Lynparza, Similar Therapies

OncoSec, Merck Partner to Test Immunotherapy Combo in Phase 2 Trial for Triple-negative Breast Cancer

Poor Prognosis for Breast Cancers Diagnosed After Negative Screening Mammography

My Body, Like My House, Is Under Construction

Possible Reasons Why Tyverb/Tykerb Fails as Breast Cancer Monotherapy Explored in Study

Pin It on Pinterest